CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

MRESVIA

BLA FilingMresviaPositive
AI Analysis

Summary

Mresvia has submitted a rolling BLA (Part 1 of 2) to the FDA for an RSV vaccine designed to prevent lower and acute respiratory tract disease in adults aged 60 and older.

Outcome Details

Rolling BLA submission (Part 1 of 2)

Importance:7/10
Sentiment:
0.50
RSVvaccinerolling submissionelderlyBLA
Related Companies

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on August 10, 2026 7:06 PM

Read Original